Close Menu

NEW YORK – Axovant Gene Therapies, a drugmaker focused on neurological diseases, has partnered with genetic testing firm Invitae to launch a free genetic testing and counseling program for children, called Detect Lysosomal Storage Diseases.

The program aims to reduce misdiagnosis and underdiagnosis of lysosomal storage disorders (LSDs) GM1 and GM2 gangliosidosis, otherwise known as Tay-Sachs and Sandhoff disease. Within the program, Invitae will provide free genetic testing on a 53-gene panel and counseling to patients suspected of having an LSD.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nature News reports on how meeting cancellations and related costs are affecting scientific societies.

In a new ruling, Canada's Supreme Court upheld the country's genetic non-discrimination law, the Canadian Press reports.

COVID-19 vaccine developers aim to avoid a complication that has affected efforts to develop vaccines for other diseases, the Wall Street Journal reports.

In PLOS this week: analysis of insertions throughout Shigella genomes, antigen production in malaria parasites, and more.